J F Martin

Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial

Daniel K. Burns, Robert Alexander, Kathleen A. Welsh‐Bohmer et al. · The Lancet Neurology · 2021 · 108 citations

Neurodegenerative Diseases, Neuropsychology, Alzheimer's Disease +11

Double-blind controlled trial of prostacyclin in cerebral infarction.

J F Martin, Neveen A. T. Hamdy, J Nicholl et al. · Stroke · 1985 · 54 citations · Full text

Cerebrovascular Disease, Thirty-two Patients, Blood Pressure +17

Differences between the Plasma Indocyanine Green Disappearance Rates of Normal Men and Women

J F Martin, M Mikulecký, Terrence F. Blaschke et al. · Experimental Biology and Medicine · 1975 · 30 citations

Drug Analysis, Hepatology, Health Sciences +15